INNOVATE Corp. Q4 Revenue Soars 61.7% to $382.7m, Backlog Hits $1.8b
INNOVATE Corp. posted Q4 revenue of $382.7m, up 61.7%, and full-year revenue of $1.246b, up 12.5%, while net loss narrowed 53.8% to $7.8m in Q4. Backlog swelled to $1.8b, and adjusted EBITDA climbed 63.3% to $24.5m, driven by Infrastructure and Life Sciences segments.
1. Financial Results
INNOVATE reported Q4 revenue of $382.7 million, up 61.7% year-on-year, and full-year revenue of $1.246 billion, up 12.5%. The net loss narrowed 53.8% to $7.8 million in Q4, while adjusted EBITDA rose 63.3% to $24.5 million.
2. Infrastructure Momentum
DBM Global drove Q4 revenue of $373.9 million, up 65.7%, with net income of $10.6 million and adjusted EBITDA of $28.0 million despite margin compression. Backlog, including awarded but unsigned contracts, reached $1.8 billion, reflecting robust project visibility.
3. Life Sciences Growth
MediBeacon secured FDA approval for its next-gen TGFR System and initiated its Center of Excellence rollout, while R2 locked a minimum three-year purchase commitment for 600 systems in China and reported full-year system sales growth of 38.2%.
4. Spectrum Developments
Spectrum Broadcasting faced Q4 revenue softness at $5.7 million and adjusted EBITDA of $1.0 million, but recent network launches and favorable FCC rulings should boost 2026 performance, with opportunities to expand into over 40 new markets.